About
Oban BioPharma develops GPCR allosteric therapeutics using AI-powered computational structural analysis to target metabolic and CNS diseases.
Explore Oban BioPharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.